AMERICAN SHARED HOSPITAL SERVICES Operating Lease Cost
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Operating Lease Cost of $133.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for the quarter ending 2026-06-30 was $133.00K, a 66.25% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for the quarter ending 2026-03-31 was $133.00K, a 15.29% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for the quarter ending 2025-12-31 was $341.00K, a 37.50% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for the quarter ending 2025-09-30 was $76.00K, a 42.86% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for fiscal 2025 was $654.00K, a 40.04% increase from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for fiscal 2024 was $467.00K, a 54.64% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for fiscal 2023 was $302.00K, a 25.62% decline from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES operating lease, cost for fiscal 2022 was $406.00K, a 15.67% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $133.00K 10-Q · filed 2026-08-13 | $266.00K 10-Q · filed 2026-08-13 | $607.00K derived: sum of 3 quarters · filed 2026-08-13 | $683.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $133.00K 10-Q · filed 2026-05-14 | $474.00K derived: sum of 2 quarters · filed 2026-05-14 | $550.00K derived: sum of 3 quarters · filed 2026-05-14 | $630.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $341.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $417.00K derived: sum of 2 quarters · filed 2026-03-31 | $497.00K derived: sum of 3 quarters · filed 2026-08-13 | $654.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $76.00K 10-Q/A · filed 2026-01-16 | $156.00K derived: sum of 2 quarters · filed 2026-08-13 | $313.00K 10-Q/A · filed 2026-01-16 | $561.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $80.00K 10-Q · filed 2026-08-13 | $237.00K 10-Q · filed 2026-08-13 | $485.00K derived: sum of 3 quarters · filed 2026-08-13 | $618.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $157.00K 10-Q · filed 2026-05-14 | $405.00K derived: sum of 2 quarters · filed 2026-05-14 | $538.00K derived: sum of 3 quarters · filed 2026-05-14 | $552.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $248.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $381.00K derived: sum of 2 quarters · filed 2026-03-31 | $395.00K derived: sum of 3 quarters · filed 2026-03-31 | $467.00K 10-K · filed 2026-03-31 | $303.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $133.00K 10-Q/A · filed 2026-01-16 | $147.00K derived: sum of 2 quarters · filed 2026-01-16 | $219.00K 10-Q/A · filed 2026-01-16 | $205.00K derived: sum of 4 quarters · filed 2026-01-16 | |
| 2024-06-30 | $14.00K 10-Q · filed 2025-08-13 | $35.00K 10-Q · filed 2025-08-13 | $72.00K derived: sum of 3 quarters · filed 2025-08-13 | $131.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $21.00K 10-Q · filed 2025-05-15 | $58.00K derived: sum of 2 quarters · filed 2025-05-15 | $117.00K derived: sum of 3 quarters · filed 2025-05-15 | $220.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $96.00K derived: sum of 2 quarters · filed 2025-04-04 | $199.00K derived: sum of 3 quarters · filed 2025-04-04 | $302.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | $59.00K 10-Q · filed 2024-11-14 | $162.00K derived: sum of 2 quarters · filed 2024-11-14 | $265.00K 10-Q · filed 2024-11-14 | $368.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $103.00K 10-Q · filed 2024-08-14 | $206.00K 10-Q · filed 2024-08-14 | $309.00K derived: sum of 3 quarters · filed 2024-08-14 | $411.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $103.00K 10-Q · filed 2024-05-15 | $206.00K derived: sum of 2 quarters · filed 2024-05-15 | $308.00K derived: sum of 3 quarters · filed 2024-05-15 | $409.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $205.00K derived: sum of 2 quarters · filed 2024-04-01 | $306.00K derived: sum of 3 quarters · filed 2024-04-01 | $406.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $102.00K 10-Q · filed 2023-11-14 | $203.00K derived: sum of 2 quarters · filed 2023-11-14 | $303.00K 10-Q · filed 2023-11-14 | $396.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $101.00K 10-Q · filed 2023-08-14 | $202.00K 10-Q · filed 2023-08-14 | $294.00K derived: sum of 3 quarters · filed 2023-08-14 | $381.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-12 | $193.00K derived: sum of 2 quarters · filed 2023-05-12 | $280.00K derived: sum of 3 quarters · filed 2023-05-12 | $366.00K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $180.00K derived: sum of 2 quarters · filed 2023-03-31 | $266.00K derived: sum of 3 quarters · filed 2023-03-31 | $351.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $87.00K 10-Q · filed 2022-11-10 | $173.00K derived: sum of 2 quarters · filed 2022-11-10 | $258.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $86.00K 10-Q · filed 2022-08-15 | $171.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |